News on Heparin_Lyase from BioPortfolio.com http://www.BioPortfolio.com Consolidated Heparin_Lyase news from BioPortfolio.com Wed, 10 Feb 2010 08:39:47 GMT en Excelsior Medical receives Canadian marketing license for new, pre-filled catheter lock syringehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039831&HITNO=0&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039831&THISHREF=http://c.moreover.com/click/here.pl%3fz2538410910%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039831&HITNO=0&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039831&THISHREF=http://c.moreover.com/click/here.pl%3fz2538410910%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: PolyMedix Announces Planned Milestones for 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039973&HITNO=1&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039973&THISHREF=http://c.moreover.com/click/here.pl%3fz2538503941%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039973&HITNO=1&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039973&THISHREF=http://c.moreover.com/click/here.pl%3fz2538503941%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Excelsior Medicals New Catheter Lock Solution Approved by Health Canadahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037029&HITNO=2&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037029&THISHREF=http://c.moreover.com/click/here.pl%3fz2536861353%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037029&HITNO=2&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037029&THISHREF=http://c.moreover.com/click/here.pl%3fz2536861353%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034526&HITNO=3&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034526&THISHREF=http://c.moreover.com/click/here.pl%3fz2535838022%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034526&HITNO=3&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034526&THISHREF=http://c.moreover.com/click/here.pl%3fz2535838022%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: PolyMedix Announces Planned Milestones for 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037856&HITNO=4&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037856&THISHREF=http://c.moreover.com/click/here.pl%3fz2537334210%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037856&HITNO=4&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037856&THISHREF=http://c.moreover.com/click/here.pl%3fz2537334210%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: PolyMedix Announces Planned Milestones for 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035234&HITNO=5&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035234&THISHREF=http://c.moreover.com/click/here.pl%3fz2536162758%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035234&HITNO=5&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035234&THISHREF=http://c.moreover.com/click/here.pl%3fz2536162758%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: PolyMedix Announces Planned Milestones for 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035957&HITNO=6&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035957&THISHREF=http://c.moreover.com/click/here.pl%3fz2536432438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035957&HITNO=6&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035957&THISHREF=http://c.moreover.com/click/here.pl%3fz2536432438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Export amount of Heparin in Nov. 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036005&HITNO=7&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036005&THISHREF=http://c.moreover.com/click/here.pl%3fz2536462121%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036005&HITNO=7&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036005&THISHREF=http://c.moreover.com/click/here.pl%3fz2536462121%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthoo.com: Report on Swedish life science clusterhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038590&HITNO=8&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038590&THISHREF=http://c.moreover.com/click/here.pl%3fz2537667584%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038590&HITNO=8&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038590&THISHREF=http://c.moreover.com/click/here.pl%3fz2537667584%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMTB Europe: FDA: drug safety benefits of import inspection system easy to Predicthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037451&HITNO=9&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037451&THISHREF=http://c.moreover.com/click/here.pl%3fz2537085030%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037451&HITNO=9&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037451&THISHREF=http://c.moreover.com/click/here.pl%3fz2537085030%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIn-Pharmatechnologist: Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of thehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029834&HITNO=10&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029834&THISHREF=http://c.moreover.com/click/here.pl%3fz2533293618%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029834&HITNO=10&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029834&THISHREF=http://c.moreover.com/click/here.pl%3fz2533293618%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEON: Bridging anticoagulation discrepancies detected among US hospitalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027091&HITNO=11&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027091&THISHREF=http://c.moreover.com/click/here.pl%3fz2531785121%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027091&HITNO=11&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027091&THISHREF=http://c.moreover.com/click/here.pl%3fz2531785121%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedWire News: Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 causes of death in the U.S.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029417&HITNO=12&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029417&THISHREF=http://c.moreover.com/click/here.pl%3fz2533129890%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029417&HITNO=12&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029417&THISHREF=http://c.moreover.com/click/here.pl%3fz2533129890%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of thehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029364&HITNO=13&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029364&THISHREF=http://c.moreover.com/click/here.pl%3fz2533110919%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029364&HITNO=13&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029364&THISHREF=http://c.moreover.com/click/here.pl%3fz2533110919%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire: Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 causes of death in the U.S.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029310&HITNO=14&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029310&THISHREF=http://c.moreover.com/click/here.pl%3fz2533079925%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029310&HITNO=14&MSIZE=143&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Heparin_Lyase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029310&THISHREF=http://c.moreover.com/click/here.pl%3fz2533079925%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: